{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-24-000570","form_type":"8-K","ticker":"AMIX","cik":"0001617867","company_name":"Autonomix Medical, Inc.","filed_at":"2024-01-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.827034+00:00","generated_at":"2026-06-06T13:37:15.328644+00:00","sec_items":["3.02","8.01","7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Autonomix Medical closes $11.2M IPO, regains cardiology rights via $8M warrant deal","bullets":["IPO closed Jan 26: 2,234,222 shares at $5.00, gross proceeds $11,171,110 before expenses.","Regained exclusive worldwide cardiology rights from Impulse Medical in exchange for warrant to buy 1.6M shares at $0.001 per share.","CEO Lori Bisson cites momentum and on-track first-in-human pancreatic cancer pain study this quarter.","Warrant shares subject to lockup: 12.5% for 6 months, remainder for 12 months post-IPO."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-24-000570","json":"https://secwatch.observer/filing/0001683168-24-000570.json","markdown":"https://secwatch.observer/filing/0001683168-24-000570.md","text":"https://secwatch.observer/filing/0001683168-24-000570.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1617867/000168316824000570/0001683168-24-000570-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1617867/000168316824000570/autonomix_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T13:37:15.328644+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}